CannRx · raw details

CannRx develops proprietary science-based cannabis technologies. The company specializes in sleep and pain research, as well as on developing products for oncology support, Parkinson's disease, women's health, and recreational products for the sports industry. The company's ican.sleep is a proprietary formulation that targets sleep disorders. The product has undergone extensive in-vivo trials in predictive pharmaceutical models. CannRx has also performed extensive in-vivo testing of a pain management formulation, which has demonstrated significant and rapid relief of pain. CannRx's Vapor Capture Technology is an extraction technology designed specifically for the cannabis plant. The commercialized product provides a pre-activated, highly bio-available cannabis extract with a unique cannabinoid/terpene profile. The company is also creating a patented nanoparticle technology to solubilize cannabinoids and terpenes. The process inserts the important cannabis compounds into everyday proteins, resulting in highly soluble and stable nanoparticles. CannRx is a subsidiary of Izun Pharmaceuticals Corporation, a company in the boutique pharmaceutical area of botanical medicine.